Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-2570 in Moderately to Severely Active Ulcerative Colitis
NCT07035041Phase 2Active, not recruiting
- Sponsor
- InventisBio
- Start
- May 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D-2570 in ulcerative colitis (UC), sponsored by InventisBio. Started May 2025; status: active, not recruiting.
02
Drugs
D-2570
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07035041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07035041.